(Q40262739)

19 September 2017

title

Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells (English)

1 reference

19 September 2017

1 reference

1 reference

Eleftherios P. Diamandis

8

1 reference

19 September 2017

7

0 references

author name string

Panagiotis Prezas

1

1 reference

19 September 2017

Matthias J E Arlt

2

1 reference

19 September 2017

Petar Viktorov

3

1 reference

19 September 2017

Antoninus Soosaipillai

4

1 reference

19 September 2017

Leon Holzscheiter

5

1 reference

19 September 2017

Manfred Schmitt

6

1 reference

19 September 2017

Achim Krüger

9

1 reference

19 September 2017

Viktor Magdolen

10

1 reference

19 September 2017

language of work or name

1 reference

1 June 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

387

1 reference

19 September 2017

issue

6

1 reference

19 September 2017

page(s)

807-811

1 reference

Biology of prostate-specific antigen

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Kallikrein and kinin receptor expression in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

The emerging roles of human tissue kallikreins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

A proteolytic cascade of kallikreins in the stratum corneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Inhibition of intraperitoneal tumor growth of human ovarian cancer cells by bi- and trifunctional inhibitors of tumor-associated proteolytic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Increased expression of protease M in ovarian tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

The new human tissue kallikrein gene family: structure, function, and association to disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Human tissue kallikreins: a new enzymatic cascade pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Kallikrein gene downregulation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.102

21 January 2018

Identifiers

DOI

10.1515/BC.2006.102

1 reference

19 September 2017

1 reference